Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift
Our case is unique because it provides support for pexidartinib use as upfront therapy for TGCT, instead of surgery, in selected cases.
Authors
- Giuliano Peta (ORCID: https://orcid.org/0000-0002-7313-4136)
- Emanuela Palmerini (ORCID: https://orcid.org/0000-0003-3406-6705)
- Gianmarco Tuzzato
Institutions
- Istituto Ortopedico Rizzoli (IT)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1007/s40487-024-00298-z
- Citations
- 3
- Primary Topic
- Musculoskeletal synovial abnormalities and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Daiichi Sankyo Europe